Centene Corporation
NYSE:CNCMedical - Healthcare Plans
+$0.67 today
- Market cap
- $33.39B
- Beta
- 1.09
- P/E (TTM)
- -4.7
- EPS (TTM)
- -$13.09
Volume 6.29M
Average 6.16M
CNC Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Centene CorporationNYSE: CNC
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables falls 16.1% from a year ago
Net receivables stood at $18.08B at the end of Q2 FY2026, down 16.1% from a year earlier and down 6.9% from the prior quarter. Over 3 fiscal years it compounded at +10.9% a year.
Context
- Net receivables amounted to 21.8% of total assets at the end of Q2 FY2026, down 3.2 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -16.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 18.11B USD
- Year-over-year change
- -8.2%
- 4-year CAGR
- +10.3%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 18.11B | -8.2% |
| FY2024 | 2024-12-31 | 19.71B | +26.9% |
| FY2023 | 2023-12-31 | 15.53B | +17.0% |
| FY2022 | 2022-12-31 | 13.27B | +8.4% |
| FY2021 | 2021-12-31 | 12.24B | — |
Net Receivables vs competitors
How CNC compares with its peers on the latest reported figures
- CNC's Jun 2026 net receivables of $18.08B is the 5th highest of the 9 companies compared; the peer median is $11.95B.
- Its year-over-year change of -16.1% is the 7th highest of 9, against a peer median of -0.8%.
- Net receivables amounts to 21.8% of total assets for CNC, versus a peer median of 17.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $40.31B | -0.8% | +13.4% | 15.9% | |
| Sep 2026 | $31.49B | -0.7% | +19.2% | 20.0% | |
| Sep 2026 | $24.57B | +67.7% | +9.1% | 19.2% | |
| Sep 2026 | $20.54B | -62.9% | +20.1% | 6.6% | |
| Jun 2026 | $18.08B | -16.1% | +10.9% | 21.8% | |
| Sep 2026 | $3.36B | -4.4% | +15.3% | 21.5% | |
| Sep 2026 | $2.87B | +6.7% | +25.0% | 5.0% | |
| Jun 2026 | $380.06M | -49.0% | -27.5% | 3.4% | |
| Mar 2026 | $277.68M | +29.7% | +39.7% | 22.0% | |
| Peer median (excluding CNC) | $11.95B | -0.8% | +17.3% | 17.6% | |
Competitors are the stored peer set for CNC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 13.12B | 12.07B | 17.19B | 14.06B | 17.89B |
| Short-term Investments | 1.54B | 2.32B | 2.46B | 2.62B | 0 |
| Net Receivables | 12.24B | 13.27B | 15.53B | 19.71B | 18.11B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.6B | 2.46B | 5.57B | 1.6B | 0 |
| Total Current Assets | 28.5B | 30.13B | 40.76B | 38B | 35.99B |
| Property, Plant & Equipment (Net) | 6.96B | 4.99B | 2.42B | 2.43B | 2.35B |
| Goodwill | 19.77B | 18.81B | 17.56B | 17.56B | 10.84B |
| Intangible Assets | 7.82B | 6.91B | 6.1B | 5.41B | 4.53B |
| Long-term Investments | 14.04B | 14.68B | 16.29B | 17.43B | 20.88B |
| Tax Assets | 0 | 0 | 0 | 0 | 914M |
| Other Non-current Assets | 1.28B | 1.35B | 1.53B | 1.62B | 2.16B |
| Total Non-current Assets | 49.88B | 46.74B | 43.89B | 44.45B | 41.67B |
| Total Assets | 78.38B | 76.87B | 84.64B | 82.45B | 77.66B |
| Account Payables | 8.29B | 9.35B | 16.25B | 13.02B | 20.54B |
| Short-term Debt | 267M | 82M | 119M | 110M | 196M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 434M | 478M | 715M | 661M | 736M |
| Other Current Liabilities | 14.24B | 16.75B | 18B | 18.31B | (50M) |
| Total Current Liabilities | 25.77B | 28.46B | 36.72B | 34.26B | 21.48B |
| Long-term Debt | 18.57B | 17.94B | 17.71B | 18.42B | 17.97B |
| Deferred Tax Liabilities | 1.41B | 615M | 641M | 684M | 1.75B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.99B | 2.48B | 2.74B | 1.83B | 15.8B |
| Total Non-current Liabilities | 25.59B | 24.17B | 21.97B | 21.67B | 36.13B |
| Total Liabilities | 51.35B | 52.63B | 58.69B | 55.94B | 57.61B |
| Common Stock | 1M | 1M | 1M | 1M | 1M |
| Retained Earnings | 8.14B | 9.34B | 12.04B | 15.35B | 8.67B |
| Accumulated OCI | 77M | (1.13B) | (652M) | (504M) | (58M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 227M | 180M | 116M | 100M | 103M |
| Total Equity | 27.02B | 24.24B | 25.96B | 26.51B | 20.06B |
| Total Debt | 22.66B | 21.33B | 18.88B | 19.43B | 18.78B |
| Net Debt | 9.54B | 9.26B | 1.68B | 5.37B | 889M |
Centene Corporation
NYSE:CNC
Intrinsic Alpha fair value
Locked
Current Price
$67.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.